related symptoms that might suggest structural or histological abnormality e.g. intermenstrual or post-coital bleeding, pelvic pain and/or pressure symptoms
impact on quality of life and other factors that may determine treatment options (such as presence of comorbidity)
when diagnosing heavy menstrual bleeding (HMB), clinicians should take into account the range and natural variability in menstrual cycles and blood loss - the clinician should also discuss this variation with the woman
if the woman has a history of HMB without other related symptoms (such as persistent intermenstrual bleeding, pelvic pain and/or pressure symptoms, that might suggest uterine cavity abnormality, histological abnormality, adenomyosis or fibroid), consider pharmacological treatment without carrying out a physical examination (unless the treatment chosen is levonorgestrel-releasing intrauterine system [LNG IUS])
if the history suggests HMB with structural or histological abnormality, with symptoms such as intermenstrual or post-coital bleeding, pelvic pain and/or pressure symptoms, a physical examination and/or other investigations (such as ultrasound) should be performed
measuring menstrual blood loss is not routinely recommended for HMB
NICE emphasise that whether menstrual blood loss is a problem should be determined not by measuring blood loss but by the woman herself
Reference:
Heavy menstrual bleeding: assessment and management. NG88. NICE Guideline (March 2018 - updated May 2021)
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page